{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:50:17Z","timestamp":1776408617927,"version":"3.51.2"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T00:00:00Z","timestamp":1412812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s11904-014-0236-6","type":"journal-article","created":{"date-parts":[[2014,10,8]],"date-time":"2014-10-08T04:36:36Z","timestamp":1412742996000},"page":"447-458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Contraceptive Methods and Risk of HIV Acquisition or Female-to-Male Transmission"],"prefix":"10.1007","volume":"11","author":[{"given":"Lisa B.","family":"Haddad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea B.","family":"Polis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anandi N.","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athena P.","family":"Kourtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igho","family":"Ofotokun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,9]]},"reference":[{"issue":"4","key":"236_CR1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1728-4465.2010.00250.x","volume":"41","author":"S Singh","year":"2010","unstructured":"Singh S, Sedgh G, Hussain R. Unintended pregnancy: worldwide levels, trends, and outcomes. Stud Fam Plan. 2010;41(4):241\u201350.","journal-title":"Stud Fam Plan"},{"issue":"2","key":"236_CR2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bpobgyn.2008.11.007","volume":"23","author":"I Mavranezouli","year":"2009","unstructured":"Mavranezouli I. Health economics of contraception. Best Pract Res Clin Obstet Gynaecol. 2009;23(2):187\u201398.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"236_CR3","unstructured":"Singh S, Darroch JE. Adding it up: costs and benefits of contraceptive services: estimates for 2012. 2012."},{"issue":"Suppl 2","key":"236_CR4","doi-asserted-by":"crossref","first-page":"ii54","DOI":"10.1136\/sti.2008.030098","volume":"84","author":"R Wilcher","year":"2008","unstructured":"Wilcher R et al. From effectiveness to impact: contraception as an HIV prevention intervention. Sex Transm Infect. 2008;84 Suppl 2:ii54\u201360.","journal-title":"Sex Transm Infect"},{"key":"236_CR5","volume-title":"Hormonal contraception and HIV technical statement","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Hormonal contraception and HIV technical statement. Geneva: World Health Organization; 2012."},{"key":"236_CR6","unstructured":"The Inter-agency Task Team for Prevention and Treatment of HIV Infection in Pregnant Women, M, and their Children. Preventing HIV and unintended pregnancies: strategic framework 2011\u20132015. 2012. http:\/\/www.unfpa.org\/webdav\/site\/global\/shared\/documents\/publications\/2012\/PreventingHIV_UnintendedPregnancies_SF2011_2015.pdf ."},{"issue":"Suppl 1","key":"236_CR7","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/QAD.0000000000000041","volume":"27","author":"B Johnston","year":"2013","unstructured":"Johnston B et al. Meeting the family planning needs of women living with HIV in US government global health programs. AIDS. 2013;27 Suppl 1:S121\u20135.","journal-title":"AIDS"},{"key":"236_CR8","volume-title":"Dissemination and evaluation of the 2014 guidance statement on hormonal contraceptive methods for women at high risk and living with HIV","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Dissemination and evaluation of the 2014 guidance statement on hormonal contraceptive methods for women at high risk and living with HIV. Geneva: WHO; 2014. This report reviews the most recent evidence and summarizes the current guidelines on the topic from the World Health Organization."},{"issue":"5","key":"236_CR9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/QAD.0b013e32835bb672","volume":"27","author":"SJ Phillips","year":"2013","unstructured":"Phillips SJ, Curtis KM, Polis CB. Effect of hormonal contraceptive methods on HIV disease progression: a systematic review. AIDS. 2013;27(5):787\u201394.","journal-title":"AIDS"},{"issue":"9","key":"236_CR10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(13)70155-5","volume":"13","author":"CB Polis","year":"2013","unstructured":"Polis CB, Curtis KM. Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infect Dis. 2013;13(9):797\u2013808.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"236_CR11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/QAD.0b013e32835ad539","volume":"27","author":"CB Polis","year":"2013","unstructured":"Polis CB, Phillips SJ, Curtis KM. Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence. AIDS. 2013;27(4):493\u2013505. This is a systematic review of the literature through 2012 evaluating the epidemiological evidence on use of various hormonal contraceptive methods and female-to-male HIV transmission.","journal-title":"AIDS"},{"issue":"4","key":"236_CR12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.contraception.2014.07.009","volume":"90","author":"CB Polis","year":"2014","unstructured":"Polis CB et al. Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. Contraception. 2014;90(4):360\u201390. This is a systematic review of the epidemiological evidence on use of evaluating use of various hormonal contraceptive methods and HIV acquisition in women.","journal-title":"Contraception"},{"key":"236_CR13","volume-title":"Contraceptive technology","author":"R Hatcher","year":"2011","unstructured":"Hatcher R et al. Contraceptive technology. 20th ed. New York: Ardent Media; 2011.","edition":"20"},{"key":"236_CR14","volume-title":"DHS working papers\u2014men\u2019s condom use in higher-risk sex: trends and determinants in five Sub-Saharan countries","author":"T Adair","year":"2008","unstructured":"Adair T. DHS working papers\u2014men\u2019s condom use in higher-risk sex: trends and determinants in five Sub-Saharan countries. Maryland: USAID; 2008."},{"issue":"9583","key":"236_CR15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(07)60950-7","volume":"370","author":"NS Padian","year":"2007","unstructured":"Padian NS et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007;370(9583):251\u201361.","journal-title":"Lancet"},{"key":"236_CR16","first-page":"CD003939","volume":"4","author":"D Wilkinson","year":"2002","unstructured":"Wilkinson D et al. Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men. Cochrane Database Syst Rev. 2002;4:CD003939.","journal-title":"Cochrane Database Syst Rev"},{"key":"236_CR17","first-page":"CD003936","volume":"4","author":"D Wilkinson","year":"2002","unstructured":"Wilkinson D et al. Nonoxynol-9 for preventing vaginal acquisition of HIV infection by women from men. Cochrane Database Syst Rev. 2002;4:CD003936.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"236_CR18","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/humrep\/dem003","volume":"22","author":"P Frank-Herrmann","year":"2007","unstructured":"Frank-Herrmann P et al. The effectiveness of a fertility awareness based method to avoid pregnancy in relation to a couple\u2019s sexual behaviour during the fertile time: a prospective longitudinal study. Hum Reprod. 2007;22(5):1310\u20139.","journal-title":"Hum Reprod"},{"issue":"9","key":"236_CR19","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1001\/archderm.1995.01690210094016","volume":"131","author":"J Trussell","year":"1995","unstructured":"Trussell J. Contraceptive efficacy. Arch Dermatol. 1995;131(9):1064\u20138.","journal-title":"Arch Dermatol"},{"key":"236_CR20","unstructured":"United Nations. World contraceptive pattern 2013. 2013 [June 21, 2014]. http:\/\/www.un.org\/en\/development\/desa\/population\/publications\/pdf\/family\/worldContraceptivePatternsWallChart2013.pdf ."},{"issue":"1","key":"236_CR21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1473-3099(11)70247-X","volume":"12","author":"R Heffron","year":"2012","unstructured":"Heffron R et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis. 2012;12(1):19\u201326. This frequently cited paper is a secondary analysis from a large cohort study. The analysis suggested an increased risk of HIV acquisition and transmission to men associated with use of injectable contraception, and increased global attention to this potential risk.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"236_CR22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/00002030-200403050-00017","volume":"18","author":"L Lavreys","year":"2004","unstructured":"Lavreys L et al. Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. AIDS. 2004;18(4):695\u20137.","journal-title":"AIDS"},{"issue":"10","key":"236_CR23","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nm1096-1084","volume":"2","author":"PA Marx","year":"1996","unstructured":"Marx PA et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med. 1996;2(10):1084\u20139.","journal-title":"Nat Med"},{"issue":"1","key":"236_CR24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002030-199801000-00009","volume":"12","author":"SH Kapiga","year":"1998","unstructured":"Kapiga SH et al. The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS. 1998;12(1):75\u201384.","journal-title":"AIDS"},{"issue":"1","key":"236_CR25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/ije\/dyl251","volume":"36","author":"L Myer","year":"2007","unstructured":"Myer L et al. Prospective study of hormonal contraception and women\u2019s risk of HIV infection in South Africa. Int J Epidemiol. 2007;36(1):166\u201374.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"236_CR26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1479-828X.1997.tb02224.x","volume":"37","author":"S Taneepanichskul","year":"1997","unstructured":"Taneepanichskul S, Phuapradit W, Chaturachinda K. Association of contraceptives and HIV-1 infection in Thai female commercial sex workers. Aust N Z J Obstet Gynaecol. 1997;37(1):86\u20138.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"236_CR27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00002030-200301240-00014","volume":"17","author":"M Kiddugavu","year":"2003","unstructured":"Kiddugavu M et al. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS. 2003;17(2):233\u201340.","journal-title":"AIDS"},{"issue":"1","key":"236_CR28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/QAD.0b013e3280117c8b","volume":"21","author":"CS Morrison","year":"2007","unstructured":"Morrison CS et al. Hormonal contraception and the risk of HIV acquisition. AIDS. 2007;21(1):85\u201395.","journal-title":"AIDS"},{"issue":"4","key":"236_CR29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/QAD.0b013e32834fa13d","volume":"26","author":"CS Morrison","year":"2012","unstructured":"Morrison CS et al. Hormonal contraception and the risk of HIV acquisition among women in South Africa. AIDS. 2012;26(4):497\u2013504.","journal-title":"AIDS"},{"issue":"1","key":"236_CR30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/QAD.0b013e3280117cb5","volume":"21","author":"M Bulterys","year":"2007","unstructured":"Bulterys M et al. Hormonal contraception and incident HIV-1 infection: new insight and continuing challenges. AIDS. 2007;21(1):97\u20139.","journal-title":"AIDS"},{"issue":"1","key":"236_CR31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/ije\/dyl304","volume":"36","author":"CS Morrison","year":"2007","unstructured":"Morrison CS. Commentary: hormonal contraception and HIV acquisition\u2014current evidence and ongoing research needs. Int J Epidemiol. 2007;36(1):175\u20137.","journal-title":"Int J Epidemiol"},{"issue":"Suppl 1","key":"236_CR32","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/QAD.0000000000000036","volume":"27","author":"CB Polis","year":"2013","unstructured":"Polis CB et al. Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches. AIDS. 2013;27 Suppl 1:S35\u201343.","journal-title":"AIDS"},{"issue":"3","key":"236_CR33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/QAD.0b013e32834f990f","volume":"26","author":"H Wand","year":"2012","unstructured":"Wand H, Ramjee G. The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. AIDS. 2012;26(3):375\u201380.","journal-title":"AIDS"},{"issue":"13","key":"236_CR34","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1097\/QAD.0b013e328270388a","volume":"21","author":"JM Baeten","year":"2007","unstructured":"Baeten JM et al. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS. 2007;21(13):1771\u20137.","journal-title":"AIDS"},{"issue":"11","key":"236_CR35","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/QAD.0b013e32833a2537","volume":"24","author":"CS Morrison","year":"2010","unstructured":"Morrison CS et al. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS. 2010;24(11):1778\u201381.","journal-title":"AIDS"},{"issue":"8","key":"236_CR36","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1473-3099(12)70153-6","volume":"12","author":"R Heffron","year":"2012","unstructured":"Heffron R et al. Use of hormonal contraceptives and risk of HIV-1 transmission\u2014authors\u2019 reply. Lancet Infect Dis. 2012;12(8):510\u20131.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"236_CR37","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/QAI.0b013e3181bc4869","volume":"53","author":"SE Reid","year":"2010","unstructured":"Reid SE et al. Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. J Acquir Immune Defic Syndr. 2010;53(5):606\u201313.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"236_CR38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.contraception.2007.02.002","volume":"75","author":"I Kleinschmidt","year":"2007","unstructured":"Kleinschmidt I et al. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception. 2007;75(6):461\u20137.","journal-title":"Contraception"},{"issue":"6","key":"236_CR39","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/QAD.0b013e32835da401","volume":"27","author":"SI McCoy","year":"2013","unstructured":"McCoy SI et al. Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa. AIDS. 2013;27(6):1001\u20139.","journal-title":"AIDS"},{"key":"236_CR40","unstructured":"Morrison C, et al. Hormonal contraception and HIV infection: results from a large individual participant data meta-analysis. Presented at AIDS 2014, July 20\u201325, 2014: Melbourne, Australia."},{"key":"236_CR41","unstructured":"Wall K, et al. Weighing 17\u00a0years of evidence: does hormonal contraception increase HIV acquisition risk among Zambian women in discordant couples? Presented at AIDS 2014, July 20\u201325, 2014: Melbourne, Australia."},{"issue":"Suppl 1","key":"236_CR42","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/QAD.0000000000000045","volume":"27","author":"T Lutalo","year":"2013","unstructured":"Lutalo T et al. Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples. AIDS. 2013;27 Suppl 1:S27\u201334.","journal-title":"AIDS"},{"issue":"1","key":"236_CR43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1210\/er.2009-0018","volume":"31","author":"Z Hel","year":"2010","unstructured":"Hel Z, Stringer E, Mestecky J. Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocr Rev. 2010;31(1):79\u201397. This paper reviews the potential biologic mechanisms from hormones that could affect HIV risk.","journal-title":"Endocr Rev"},{"issue":"1","key":"236_CR44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/sti.74.1.11","volume":"74","author":"C Sonnex","year":"1998","unstructured":"Sonnex C. Influence of ovarian hormones on urogenital infection. Sex Transm Infect. 1998;74(1):11\u20139.","journal-title":"Sex Transm Infect"},{"issue":"1","key":"236_CR45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.virol.2006.04.004","volume":"352","author":"N Trunova","year":"2006","unstructured":"Trunova N et al. Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology. 2006;352(1):169\u201377.","journal-title":"Virology"},{"issue":"3","key":"236_CR46","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1086\/315776","volume":"182","author":"SM Smith","year":"2000","unstructured":"Smith SM, Baskin GB, Marx PA. Estrogen protects against vaginal transmission of simian immunodeficiency virus. J Infect Dis. 2000;182(3):708\u201315.","journal-title":"J Infect Dis"},{"issue":"12","key":"236_CR47","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/01.aids.0000131393.76221.cc","volume":"18","author":"SM Smith","year":"2004","unstructured":"Smith SM et al. Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS. 2004;18(12):1637\u201343.","journal-title":"AIDS"},{"issue":"6","key":"236_CR48","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/gme.0b013e3180587eb5","volume":"14","author":"GI Gorodeski","year":"2007","unstructured":"Gorodeski GI. Estrogen modulation of epithelial permeability in cervical-vaginal cells of premenopausal and postmenopausal women. Menopause. 2007;14(6):1012\u20139.","journal-title":"Menopause"},{"issue":"1","key":"236_CR49","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1210\/en.2006-1120","volume":"148","author":"GI Gorodeski","year":"2007","unstructured":"Gorodeski GI. Estrogen decrease in tight junctional resistance involves matrix-metalloproteinase-7-mediated remodeling of occludin. Endocrinology. 2007;148(1):218\u201331.","journal-title":"Endocrinology"},{"issue":"5","key":"236_CR50","doi-asserted-by":"crossref","first-page":"e97767","DOI":"10.1371\/journal.pone.0097767","volume":"9","author":"D Goode","year":"2014","unstructured":"Goode D et al. Sex hormones selectively impact the endocervical mucosal microenvironment: implications for HIV transmission. PLoS ONE. 2014;9(5):e97767.","journal-title":"PLoS ONE"},{"key":"236_CR51","doi-asserted-by":"crossref","unstructured":"Bahamondes MV, et al. Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate. Contraception, 2014.","DOI":"10.1016\/j.contraception.2014.01.024"},{"key":"236_CR52","doi-asserted-by":"crossref","unstructured":"Mitchell CM, et al. Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells. J Infect Dis, 2014.","DOI":"10.1093\/infdis\/jiu176"},{"issue":"Suppl 1","key":"236_CR53","first-page":"S51","volume":"14","author":"WH Kutteh","year":"1998","unstructured":"Kutteh WH, Moldoveanu Z, Mestecky J. Mucosal immunity in the female reproductive tract: correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res Hum Retrovir. 1998;14 Suppl 1:S51\u20135.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"1","key":"236_CR54","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0897.1997.tb00190.x","volume":"37","author":"HD White","year":"1997","unstructured":"White HD et al. Mucosal immunity in the human female reproductive tract: cytotoxic T lymphocyte function in the cervix and vagina of premenopausal and postmenopausal women. Am J Reprod Immunol. 1997;37(1):30\u20138.","journal-title":"Am J Reprod Immunol"},{"issue":"5","key":"236_CR55","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1128\/CDLI.10.5.944-949.2003","volume":"10","author":"FX Lu","year":"2003","unstructured":"Lu FX et al. Effects of ovarian steroids on immunoglobulin-secreting cell function in healthy women. Clin Diagn Lab Immunol. 2003;10(5):944\u20139.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"236_CR56","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4049\/jimmunol.181.2.969","volume":"181","author":"TL Cherpes","year":"2008","unstructured":"Cherpes TL et al. Medroxyprogesterone acetate inhibits CD8+ T cell viral-specific effector function and induces herpes simplex virus type 1 reactivation. J Immunol. 2008;181(2):969\u201375.","journal-title":"J Immunol"},{"issue":"5","key":"236_CR57","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-0897.1999.tb00107.x","volume":"42","author":"G Laskarin","year":"1999","unstructured":"Laskarin G et al. Progesterone directly and indirectly affects perforin expression in cytolytic cells. Am J Reprod Immunol. 1999;42(5):312\u201320.","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"236_CR58","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0306-4530(94)00059-J","volume":"20","author":"JM Scanlan","year":"1995","unstructured":"Scanlan JM et al. Natural killer cell activity is reduced in association with oral contraceptive use. Psychoneuroendocrinology. 1995;20(3):281\u20137.","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"236_CR59","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/gyno.2001.6153","volume":"81","author":"G Yovel","year":"2001","unstructured":"Yovel G, Shakhar K, Ben-Eliyahu S. The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells. Gynecol Oncol. 2001;81(2):254\u201362.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"236_CR60","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1089\/aid.2012.0271","volume":"29","author":"N Chandra","year":"2013","unstructured":"Chandra N et al. Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues. AIDS Res Hum Retrovir. 2013;29(3):592\u2013601.","journal-title":"AIDS Res Hum Retrovir"},{"key":"236_CR61","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1477-7827-1-116","volume":"1","author":"AE King","year":"2003","unstructured":"King AE, Critchley HO, Kelly RW. Innate immune defences in the human endometrium. Reprod Biol Endocrinol. 2003;1:116.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"236_CR62","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/157340408784246395","volume":"4","author":"DO Ochiel","year":"2008","unstructured":"Ochiel DO et al. Innate immunity in the female reproductive tract: role of sex hormones in regulating uterine epithelial cell protection against pathogens. Curr Womens Health Rev. 2008;4(2):102\u201317.","journal-title":"Curr Womens Health Rev"},{"issue":"11","key":"236_CR63","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1086\/340512","volume":"185","author":"JV Fahey","year":"2002","unstructured":"Fahey JV, Wira CR. Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J Infect Dis. 2002;185(11):1606\u201313.","journal-title":"J Infect Dis"},{"issue":"4","key":"236_CR64","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/QAD.0b013e328013d9b5","volume":"21","author":"MJ Keller","year":"2007","unstructured":"Keller MJ et al. PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity. AIDS. 2007;21(4):467\u201376.","journal-title":"AIDS"},{"issue":"3","key":"236_CR65","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.fertnstert.2007.01.046","volume":"90","author":"A Li","year":"2008","unstructured":"Li A et al. Effect of mifepristone on the expression of endometrial secretory leukocyte protease inhibitor in new medroxyprogesterone acetate users. Fertil Steril. 2008;90(3):872\u20135.","journal-title":"Fertil Steril"},{"issue":"15","key":"236_CR66","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/QAD.0b013e32834a9338","volume":"25","author":"NR Mugo","year":"2011","unstructured":"Mugo NR et al. Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples. AIDS. 2011;25(15):1887\u201395.","journal-title":"AIDS"},{"issue":"3","key":"236_CR67","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0029-7844(00)00906-6","volume":"96","author":"L Miller","year":"2000","unstructured":"Miller L et al. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol. 2000;96(3):431\u20139.","journal-title":"Obstet Gynecol"},{"issue":"Suppl 4","key":"236_CR68","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/01.aids.0000390704.35642.47","volume":"24","author":"R Hayes","year":"2010","unstructured":"Hayes R et al. Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? AIDS. 2010;24 Suppl 4:S15\u201326.","journal-title":"AIDS"},{"issue":"2","key":"236_CR69","doi-asserted-by":"crossref","first-page":"e1000416","DOI":"10.1371\/journal.pmed.1000416","volume":"8","author":"N Low","year":"2011","unstructured":"Low N et al. Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med. 2011;8(2):e1000416.","journal-title":"PLoS Med"},{"issue":"3","key":"236_CR70","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/427262","volume":"191","author":"RS McClelland","year":"2005","unstructured":"McClelland RS et al. Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study. J Infect Dis. 2005;191(3):333\u20138.","journal-title":"J Infect Dis"},{"issue":"9","key":"236_CR71","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.olq.0000137904.56037.70","volume":"31","author":"CS Morrison","year":"2004","unstructured":"Morrison CS et al. Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Sex Transm Dis. 2004;31(9):561\u20137.","journal-title":"Sex Transm Dis"},{"issue":"77","key":"236_CR72","doi-asserted-by":"crossref","first-page":"77ra29","DOI":"10.1126\/scitranslmed.3001888","volume":"3","author":"JM Baeten","year":"2011","unstructured":"Baeten JM et al. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med. 2011;3(77):77ra29.","journal-title":"Sci Transl Med"},{"issue":"22","key":"236_CR73","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1001\/jama.1993.03500220046024","volume":"269","author":"DB Clemetson","year":"1993","unstructured":"Clemetson DB et al. Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA. 1993;269(22):2860\u20134.","journal-title":"JAMA"},{"issue":"3","key":"236_CR74","doi-asserted-by":"crossref","first-page":"e17480","DOI":"10.1371\/journal.pone.0017480","volume":"6","author":"C Tanton","year":"2011","unstructured":"Tanton C et al. Correlates of HIV-1 genital shedding in Tanzanian women. PLoS ONE. 2011;6(3):e17480.","journal-title":"PLoS ONE"},{"issue":"6","key":"236_CR75","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/infdis\/170.6.1597","volume":"170","author":"J Kreiss","year":"1994","unstructured":"Kreiss J et al. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis. 1994;170(6):1597\u2013601.","journal-title":"J Infect Dis"},{"issue":"4","key":"236_CR76","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/QAD.0b013e32833433df","volume":"24","author":"CS Morrison","year":"2010","unstructured":"Morrison CS et al. Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection. AIDS. 2010;24(4):573\u201382.","journal-title":"AIDS"},{"issue":"1","key":"236_CR77","first-page":"72","volume":"6","author":"Y Henin","year":"1993","unstructured":"Henin Y et al. Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr. 1993;6(1):72\u20135.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"236_CR78","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/157016211797636017","volume":"9","author":"B Gardella","year":"2011","unstructured":"Gardella B et al. HIV shedding in cervico-vaginal secretions in pregnant women. Curr HIV Res. 2011;9(5):313\u201320.","journal-title":"Curr HIV Res"},{"issue":"3","key":"236_CR79","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/427190","volume":"191","author":"KG Ghanem","year":"2005","unstructured":"Ghanem KG et al. Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. J Infect Dis. 2005;191(3):358\u201366.","journal-title":"J Infect Dis"},{"issue":"11","key":"236_CR80","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/OLQ.0b013e3181812d15","volume":"35","author":"LF Johnson","year":"2008","unstructured":"Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis. 2008;35(11):946\u201359.","journal-title":"Sex Transm Dis"},{"issue":"5","key":"236_CR81","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00007435-200005000-00001","volume":"27","author":"K Rotchford","year":"2000","unstructured":"Rotchford K, Strum AW, Wilkinson D. Effect of coinfection with STDs and of STD treatment on HIV shedding in genital-tract secretions: systematic review and data synthesis. Sex Transm Dis. 2000;27(5):243\u20138.","journal-title":"Sex Transm Dis"},{"issue":"4","key":"236_CR82","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/COH.0b013e32833a8844","volume":"5","author":"H Ward","year":"2010","unstructured":"Ward H, Ronn M. Contribution of sexually transmitted infections to the sexual transmission of HIV. Curr Opin HIV AIDS. 2010;5(4):305\u201310.","journal-title":"Curr Opin HIV AIDS"},{"issue":"10","key":"236_CR83","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/QAD.0000000000000294","volume":"28","author":"J Radzio","year":"2014","unstructured":"Radzio J et al. Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques. AIDS. 2014;28(10):1431\u20139.","journal-title":"AIDS"},{"issue":"4","key":"236_CR84","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.contraception.2011.06.006","volume":"84","author":"D Africander","year":"2011","unstructured":"Africander D et al. Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract. Contraception. 2011;84(4):423\u201335.","journal-title":"Contraception"},{"issue":"7","key":"236_CR85","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.steroids.2011.03.001","volume":"76","author":"D Africander","year":"2011","unstructured":"Africander D, Verhoog N, Hapgood JP. Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception. Steroids. 2011;76(7):636\u201352.","journal-title":"Steroids"},{"issue":"6","key":"236_CR86","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/aji.12214","volume":"71","author":"JP Hapgood","year":"2014","unstructured":"Hapgood JP et al. Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis. Am J Reprod Immunol. 2014;71(6):505\u201312.","journal-title":"Am J Reprod Immunol"},{"issue":"5","key":"236_CR87","doi-asserted-by":"crossref","first-page":"e96497","DOI":"10.1371\/journal.pone.0096497","volume":"9","author":"Y Govender","year":"2014","unstructured":"Govender Y et al. The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor. PLoS ONE. 2014;9(5):e96497.","journal-title":"PLoS ONE"},{"issue":"15","key":"236_CR88","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1097\/00002030-199910220-00012","volume":"13","author":"BA Richardson","year":"1999","unstructured":"Richardson BA et al. Effect of intrauterine device use on cervical shedding of HIV-1 DNA. AIDS. 1999;13(15):2091\u20137.","journal-title":"AIDS"},{"key":"236_CR89","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/bmj.304.6830.809","volume":"304","author":"European Study Group on Heterosexual Transmission of HIV","year":"1992","unstructured":"European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ. 1992;304:809\u201313.","journal-title":"BMJ"},{"key":"236_CR90","author":"SL Achilles","year":"2014","unstructured":"Achilles SL et al. Changes in genital tract immune cell populations after initiation of intrauterine contraception. Am J Obstet Gynecol. 2014. doi: 10.1016\/j.ajog.2014.05.016 .","journal-title":"Am J Obstet Gynecol"},{"issue":"9338","key":"236_CR91","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(02)11079-8","volume":"360","author":"L Damme Van","year":"2002","unstructured":"Van Damme L et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002;360(9338):971\u20137.","journal-title":"Lancet"},{"key":"236_CR92","unstructured":"Centers for Disease Control and Prevention (CDC). U.S. medical eligibility criteria for contraceptive use. Morbidity and Mortality Weekly Report (MMWR), 2010."},{"issue":"9","key":"236_CR93","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.OLQ.0000078628.84288.66","volume":"30","author":"JE Anderson","year":"2003","unstructured":"Anderson JE, Santelli J, Gilbert BC. Adolescent dual use of condoms and hormonal contraception: trends and correlates 1991-2001. Sex Transm Dis. 2003;30(9):719\u201322.","journal-title":"Sex Transm Dis"},{"issue":"3","key":"236_CR94","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1542\/peds.107.3.562","volume":"107","author":"DE Greydanus","year":"2001","unstructured":"Greydanus DE, Patel DR, Rimsza ME. Contraception in the adolescent: an update. Pediatrics. 2001;107(3):562\u201373.","journal-title":"Pediatrics"},{"issue":"2","key":"236_CR95","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00126334-200310010-00010","volume":"34","author":"JE Anderson","year":"2003","unstructured":"Anderson JE, Santelli J, Mugalla C. Changes in HIV-related preventive behavior in the US population: data from national surveys, 1987-2002. J Acquir Immune Defic Syndr. 2003;34(2):195\u2013202. 1999.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"236_CR96","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S1054-139X(00)00210-X","volume":"28","author":"RA Crosby","year":"2001","unstructured":"Crosby RA et al. Correlates of using dual methods for sexually transmitted diseases and pregnancy prevention among high-risk African-American female teens. J Adolesc Health. 2001;28(5):410\u20134.","journal-title":"J Adolesc Health"},{"issue":"12","key":"236_CR97","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/archpediatrics.2010.230","volume":"164","author":"JM Sales","year":"2010","unstructured":"Sales JM et al. Differences between dual-method and non-dual-method protection use in a sample of young African American women residing in the Southeastern United States. Arch Pediatr Adolesc Med. 2010;164(12):1125\u201331.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"5","key":"236_CR98","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.contraception.2006.12.020","volume":"75","author":"C MacPhail","year":"2007","unstructured":"MacPhail C et al. Predictors of dual method use for pregnancy and HIV prevention among adolescent South African women. Contraception. 2007;75(5):383\u20139.","journal-title":"Contraception"},{"issue":"5","key":"236_CR99","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/jwh.2006.0204","volume":"16","author":"LS Massad","year":"2007","unstructured":"Massad LS et al. Contraceptive use among U.S. women with HIV. J Women\u2019s Health. 2007;16(5):657\u201366. 15409996.","journal-title":"J Women\u2019s Health"},{"key":"236_CR100","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.contraception.2014.06.003","volume":"90","author":"JA Higgins","year":"2014","unstructured":"Higgins JA et al. Dual method use at last sexual encounter: a nationally representative, episode-level analysis of US men and women. Contraception. 2014;90:399\u2013406.","journal-title":"Contraception"},{"issue":"6","key":"236_CR101","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2307\/2953414","volume":"29","author":"JS Santelli","year":"1997","unstructured":"Santelli JS et al. The use of condoms with other contraceptive methods among young men and women. Fam Plan Perspect. 1997;29(6):261\u20137.","journal-title":"Fam Plan Perspect"},{"issue":"2","key":"236_CR102","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2307\/2135909","volume":"27","author":"JS Santelli","year":"1995","unstructured":"Santelli JS et al. Combined use of condoms with other contraceptive methods among inner-city Baltimore women. Fam Plan Perspect. 1995;27(2):74\u20138.","journal-title":"Fam Plan Perspect"},{"key":"236_CR103","doi-asserted-by":"crossref","first-page":"765917","DOI":"10.1155\/2011\/765917","volume":"2011","author":"JL Brown","year":"2011","unstructured":"Brown JL et al. Multiple method contraception use among African American adolescents in four US cities. Infect Dis Obstet Gynecol. 2011;2011:765917.","journal-title":"Infect Dis Obstet Gynecol"},{"key":"236_CR104","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1471-2458-12-197","volume":"12","author":"S Cred\u00e9","year":"2012","unstructured":"Cred\u00e9 S et al. Factors impacting knowledge and use of long acting and permanent contraceptive methods by postpartum HIV positive and negative women in Cape Town, South Africa: a cross-sectional study. BMC Public Health. 2012;12:197.","journal-title":"BMC Public Health"},{"issue":"6","key":"236_CR105","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3109\/13625180903340584","volume":"14","author":"N Dhont","year":"2009","unstructured":"Dhont N et al. Improved access increases postpartum uptake of contraceptive implants among HIV-positive women in Rwanda. Eur J Contracept Reprod Health Care. 2009;14(6):420\u20135.","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"10","key":"236_CR106","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/OLQ.0b013e3181e1a162","volume":"37","author":"R Heffron","year":"2010","unstructured":"Heffron R et al. A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships. Sex Transm Dis. 2010;37(10):621\u20138.","journal-title":"Sex Transm Dis"},{"issue":"6","key":"236_CR107","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5582\/bst.2011.v5.6.255","volume":"5","author":"K Kikuchi","year":"2011","unstructured":"Kikuchi K et al. High rate of unintended pregnancies after knowing of HIV infection among HIV positive women under antiretroviral treatment in Kigali, Rwanda. Biosci Trends. 2011;5(6):255\u201363.","journal-title":"Biosci Trends"},{"issue":"Suppl 1","key":"236_CR108","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10461-009-9544-z","volume":"13","author":"F Laher","year":"2009","unstructured":"Laher F et al. A qualitative assessment of decisions affecting contraceptive utilization and fertility intentions among HIV-positive women in Soweto, South Africa. AIDS Behav. 2009;13 Suppl 1:47\u201354.","journal-title":"AIDS Behav"},{"issue":"Suppl 1","key":"236_CR109","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10461-009-9545-y","volume":"13","author":"M Nduna","year":"2009","unstructured":"Nduna M, Farlane L. Women living with HIV in South Africa and their concerns about fertility. AIDS Behav. 2009;13 Suppl 1:62\u20135.","journal-title":"AIDS Behav"},{"issue":"6","key":"236_CR110","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.contraception.2010.10.002","volume":"83","author":"CB Polis","year":"2011","unstructured":"Polis CB et al. Trends and correlates of hormonal contraceptive use among HIV-infected women in Rakai, Uganda, 1994-2006. Contraception. 2011;83(6):549\u201355.","journal-title":"Contraception"},{"issue":"1","key":"236_CR111","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.contraception.2010.10.012","volume":"84","author":"EE Ezeanolue","year":"2011","unstructured":"Ezeanolue EE et al. Contraception choices in a cohort of HIV+ women in the era of highly active antiretroviral therapy. Contraception. 2011;84(1):94\u20137.","journal-title":"Contraception"},{"issue":"7","key":"236_CR112","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1080\/09540120500431584","volume":"18","author":"MP Carrieri","year":"2006","unstructured":"Carrieri MP et al. Oral contraception and unprotected sex with occasional partners of women HIV-infected through injection drug use. AIDS Care. 2006;18(7):795\u2013800.","journal-title":"AIDS Care"},{"issue":"3","key":"236_CR113","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/sti.2010.047514","volume":"87","author":"SC Kalichman","year":"2011","unstructured":"Kalichman SC, Pellowski J, Turner C. Prevalence of sexually transmitted co-infections in people living with HIV\/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Transm Infect. 2011;87(3):183\u201390.","journal-title":"Sex Transm Infect"},{"issue":"5","key":"236_CR114","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ijid.2008.10.008","volume":"13","author":"B Taiwo","year":"2009","unstructured":"Taiwo B. Understanding transmitted HIV resistance through the experience in the USA. Int J Infect Dis. 2009;13(5):552\u20139.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"236_CR115","doi-asserted-by":"crossref","first-page":"e5690","DOI":"10.1371\/journal.pone.0005690","volume":"4","author":"MS Campbell","year":"2009","unstructured":"Campbell MS et al. HIV-1 superinfection in the antiretroviral therapy era: are seroconcordant sexual partners at risk? PLoS ONE. 2009;4(5):e5690.","journal-title":"PLoS ONE"},{"issue":"12","key":"236_CR116","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/01.aids.0000131377.28694.04","volume":"18","author":"B Brenner","year":"2004","unstructured":"Brenner B et al. Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection. AIDS (London, England). 2004;18(12):1653\u201360.","journal-title":"AIDS (London, England)"},{"issue":"6","key":"236_CR117","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.4049\/jimmunol.169.6.3301","volume":"169","author":"H Bouhlal","year":"2002","unstructured":"Bouhlal H et al. Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells. J Immunol. 2002;169(6):3301\u20136.","journal-title":"J Immunol"},{"issue":"12","key":"236_CR118","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/molehr\/gag095","volume":"9","author":"S Gutsche","year":"2003","unstructured":"Gutsche S et al. Seminal plasma induces mRNA expression of IL-1beta, IL-6 and LIF in endometrial epithelial cells in vitro. Mol Hum Reprod. 2003;9(12):785\u201391.","journal-title":"Mol Hum Reprod"},{"issue":"7","key":"236_CR119","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/molehr\/gam028","volume":"13","author":"DJ Sharkey","year":"2007","unstructured":"Sharkey DJ et al. Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells. Mol Hum Reprod. 2007;13(7):491\u2013501.","journal-title":"Mol Hum Reprod"},{"issue":"5","key":"236_CR120","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.4049\/jimmunol.1102736","volume":"188","author":"DJ Sharkey","year":"2012","unstructured":"Sharkey DJ et al. Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J Immunol. 2012;188(5):2445\u201354.","journal-title":"J Immunol"},{"issue":"5","key":"236_CR121","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/humrep\/dei496","volume":"21","author":"W Berlier","year":"2006","unstructured":"Berlier W et al. Seminal plasma promotes the attraction of Langerhans cells via the secretion of CCL20 by vaginal epithelial cells: involvement in the sexual transmission of HIV. Hum Reprod. 2006;21(5):1135\u201342.","journal-title":"Hum Reprod"},{"issue":"6","key":"236_CR122","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.4049\/jimmunol.158.6.3017","volume":"158","author":"HD White","year":"1997","unstructured":"White HD et al. CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol. 1997;158(6):3017\u201327.","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"236_CR123","first-page":"S5","volume":"14","author":"FA Plummer","year":"1998","unstructured":"Plummer FA. Heterosexual transmission of human immunodeficiency virus type 1 (HIV): interactions of conventional sexually transmitted diseases, hormonal contraception and HIV-1. AIDS Res Hum Retrovir. 1998;14 Suppl 1:S5\u201310.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"4","key":"236_CR124","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00002030-200003100-00015","volume":"14","author":"S Cu-Uvin","year":"2000","unstructured":"Cu-Uvin S et al. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS. 2000;14(4):415\u201321.","journal-title":"AIDS"},{"issue":"9293","key":"236_CR125","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(01)06653-3","volume":"358","author":"A Kovacs","year":"2001","unstructured":"Kovacs A et al. Determinants of HIV-1 shedding in the genital tract of women. Lancet. 2001;358(9293):1593\u2013601.","journal-title":"Lancet"},{"issue":"6","key":"236_CR126","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen MS et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493\u2013505.","journal-title":"N Engl J Med"},{"issue":"10","key":"236_CR127","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1089\/aid.2006.0290","volume":"23","author":"PM Flynn","year":"2007","unstructured":"Flynn PM et al. Long-term observation of adolescents initiating HAART therapy: three-year follow-Up. AIDS Res Hum Retrovir. 2007;23(10):1208\u201314.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"3","key":"236_CR128","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archpedi.157.3.249","volume":"157","author":"DA Murphy","year":"2003","unstructured":"Murphy DA et al. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med. 2003;157(3):249\u201355.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"236_CR129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/09540120020018161","volume":"13","author":"DA Murphy","year":"2001","unstructured":"Murphy DA et al. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care. 2001;13(1):27\u201340.","journal-title":"AIDS Care"},{"issue":"6","key":"236_CR130","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.contraception.2010.10.008","volume":"83","author":"M Roccio","year":"2011","unstructured":"Roccio M et al. Low-dose combined oral contraceptive and cervicovaginal shedding of human immunodeficiency virus. Contraception. 2011;83(6):564\u201370.","journal-title":"Contraception"},{"issue":"2","key":"236_CR131","first-page":"91","volume":"20","author":"M Debiaggi","year":"2001","unstructured":"Debiaggi M et al. Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy. Eur J Clin Microbiol Infect Dis. 2001;20(2):91\u20136.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 1","key":"236_CR132","first-page":"S105","volume":"14","author":"S Rasheed","year":"1998","unstructured":"Rasheed S. Infectivity and dynamics of HIV type 1 replication in the blood and reproductive tract of HIV type 1-infected women. AIDS Res Hum Retrovir. 1998;14 Suppl 1:S105\u201318.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"9731","key":"236_CR133","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/S0140-6736(10)60705-2","volume":"375","author":"D Donnell","year":"2010","unstructured":"Donnell D et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375(9731):2092\u20138.","journal-title":"Lancet"},{"key":"236_CR134","doi-asserted-by":"crossref","first-page":"c2205","DOI":"10.1136\/bmj.c2205","volume":"340","author":"J Romero Del","year":"2010","unstructured":"Del Romero J et al. Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study. BMJ. 2010;340:c2205.","journal-title":"BMJ"},{"issue":"1","key":"236_CR135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.qai.0000248352.18007.1f","volume":"44","author":"MN Neely","year":"2007","unstructured":"Neely MN et al. Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2007;44(1):38\u201342.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"15","key":"236_CR136","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/00002030-200310170-00004","volume":"17","author":"JR Fiore","year":"2003","unstructured":"Fiore JR et al. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS. 2003;17(15):2169\u201376.","journal-title":"AIDS"},{"issue":"4","key":"236_CR137","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1086\/377104","volume":"188","author":"L Andreoletti","year":"2003","unstructured":"Andreoletti L et al. Independent levels of cell-free and cell-associated human immunodeficiency virus-1 in genital-tract secretions of clinically asymptomatic, treatment-naive African women. J Infect Dis. 2003;188(4):549\u201354.","journal-title":"J Infect Dis"},{"issue":"6","key":"236_CR138","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/655889","volume":"51","author":"DN Burns","year":"2010","unstructured":"Burns DN, Dieffenbach CW, Vermund SH. Rethinking prevention of HIV type 1 infection. Clin Infect Dis. 2010;51(6):725\u201331.","journal-title":"Clin Infect Dis"},{"issue":"77","key":"236_CR139","doi-asserted-by":"crossref","first-page":"77ps11","DOI":"10.1126\/scitranslmed.3002329","volume":"3","author":"P Anton","year":"2011","unstructured":"Anton P, Herold BC. HIV transmission: time for translational studies to bridge the gap. Sci Transl Med. 2011;3(77):77ps11.","journal-title":"Sci Transl Med"},{"issue":"4","key":"236_CR140","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/QAI.0000000000000187","volume":"66","author":"S Day","year":"2014","unstructured":"Day S et al. A prospective cohort study of the effect of depot medroxyprogesterone acetate on detection of plasma and cervical HIV-1 in women initiating and continuing antiretroviral therapy. J Acquir Immune Defic Syndr. 2014;66(4):452\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"236_CR141","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. 2013 updated 7\/31\/12; cited 2013 November 14. http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/AdultandAdolescentGL.pdf ."},{"key":"236_CR142","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services, Editor."},{"issue":"24","key":"236_CR143","first-page":"449","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","unstructured":"Centers for Disease Control and Prevention (CDC). Update to CDC\u2019s U.S. medical eligibility criteria for contraceptive use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV. MMWR. 2012;61(24):449\u201352.","journal-title":"MMWR"},{"issue":"9","key":"236_CR144","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-0528.2012.03402.x","volume":"119","author":"MI Rodriguez","year":"2012","unstructured":"Rodriguez MI, Reeves MF, Caughey AB. Evaluating the competing risks of HIV acquisition and maternal mortality in Africa: a decision analysis. BJOG. 2012;119(9):1067\u201373.","journal-title":"BJOG"},{"issue":"1","key":"236_CR145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/QAD.0b013e32835a5a52","volume":"27","author":"AR Butler","year":"2013","unstructured":"Butler AR et al. Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk. AIDS. 2013;27(1):105\u201313.","journal-title":"AIDS"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-014-0236-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11904-014-0236-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-014-0236-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T03:15:42Z","timestamp":1689563742000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11904-014-0236-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,9]]},"references-count":145,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["236"],"URL":"https:\/\/doi.org\/10.1007\/s11904-014-0236-6","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,9]]}}}